For patients with rheumatic and musculoskeletal diseases (RMD), flare is uncommon following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination.
Considerable uncertainty exists about the clinical efficacy and safety of muscle relaxants for the treatment of low back pain.
In this episode of the EULAR 2021 series, Dr Elena Nikiphorou highlights the role of diet in rheumatic and musculoskeletal diseases and what clinicians should tell their patients in this regard.
Small increases in the risk for statin-associated muscle symptoms were observed for patients on high-intensity therapy.
Researchers aimed to study the correlation between irreversible organ damage and quality of life in systemic lupus erythematosus, and to identify the type of organ damage that is negatively correlated with QOL.
Includes drugs indicated for different types of arthritis as well as the form and strength the medication is available in.
Researchers compared the effectiveness of full-length vs brief mindfulness training programs for improving anxiety among patients with rheumatic disease.
NSAIDS (non-steroidal anti-inflammatory drugs) indicated for the treatment of different types of arthritis.
Researchers investigated the association between rituximab and severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases.
The rate of work-related musculoskeletal disorder (WMSD) claims from overexertion among construction workers is highest for those aged 35 to 44 years.
